185 related articles for article (PubMed ID: 3802587)
1. Secondary hyperoxalemia caused by vitamin C supplementation in regular hemodialysis patients.
Ono K
Clin Nephrol; 1986 Nov; 26(5):239-43. PubMed ID: 3802587
[TBL] [Abstract][Full Text] [Related]
2. The effect of vitamin C supplementation and withdrawal on the mortality and morbidity of regular hemodialysis patients.
Ono K
Clin Nephrol; 1989 Jan; 31(1):31-4. PubMed ID: 2914408
[TBL] [Abstract][Full Text] [Related]
3. Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients.
Canavese C; Petrarulo M; Massarenti P; Berutti S; Fenoglio R; Pauletto D; Lanfranco G; Bergamo D; Sandri L; Marangella M
Am J Kidney Dis; 2005 Mar; 45(3):540-9. PubMed ID: 15754276
[TBL] [Abstract][Full Text] [Related]
4. Reduction of elevated plasma oxalic acid by pyridoxine therapy in patients on RDT.
Balcke P; Schmidt P; Zazgornik J; Kopsa H
Proc Eur Dial Transplant Assoc; 1983; 19():308-12. PubMed ID: 6878246
[TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
6. Plasma oxalate concentration, oxalate clearance and cardiac function in patients receiving haemodialysis.
Tomson CR; Channon SM; Ward MK; Laker MF
Nephrol Dial Transplant; 1989; 4(9):792-9. PubMed ID: 2516611
[TBL] [Abstract][Full Text] [Related]
7. [Secondary oxalosis in chronic renal insufficiency].
Balcke P; Schmidt P; Zazgornik J; Kopsa H; Deutsch E
Z Urol Nephrol; 1982 Jun; 75(6):409-14. PubMed ID: 7124142
[TBL] [Abstract][Full Text] [Related]
8. Vitamin C intoxication and hyperoxalemia in chronic hemodialysis patients.
Pru C; Eaton J; Kjellstrand C
Nephron; 1985; 39(2):112-6. PubMed ID: 3974772
[TBL] [Abstract][Full Text] [Related]
9. Oxalate metabolism in end-stage renal disease: the effect of ascorbic acid and pyridoxine.
Morgan SH; Maher ER; Purkiss P; Watts RW; Curtis JR
Nephrol Dial Transplant; 1988; 3(1):28-32. PubMed ID: 3132636
[TBL] [Abstract][Full Text] [Related]
10. [Oxalic acid metabolism in chronic renal failure].
Balcke P
Wien Klin Wochenschr Suppl; 1985; 160():1-15. PubMed ID: 3859955
[TBL] [Abstract][Full Text] [Related]
11. Hyperoxalemia in renal failure and the role of hemoperfusion and hemodialysis in primary oxalosis.
Ahmad S; Hatch M
Nephron; 1985; 41(3):235-40. PubMed ID: 4058624
[TBL] [Abstract][Full Text] [Related]
12. Effect of vitamin C supplementation on renal oxalate deposits in five-sixths nephrectomized rats.
Ono K; Ono H; Ono T; Kikawa K; Oh Y
Nephron; 1989; 51(4):536-9. PubMed ID: 2739830
[TBL] [Abstract][Full Text] [Related]
13. Effects of ascorbic acid and pyridoxine supplementation on oxalate metabolism in peritoneal dialysis patients.
Shah GM; Ross EA; Sabo A; Pichon M; Reynolds RD; Bhagavan H
Am J Kidney Dis; 1992 Jul; 20(1):42-9. PubMed ID: 1621677
[TBL] [Abstract][Full Text] [Related]
14. Plasma oxalate in patients receiving continuous ambulatory peritoneal dialysis.
Tomson CR; Channon SM; Parkinson IS; Owen JP; Ward MK; Simpson JM; Laker MF
Nephrol Dial Transplant; 1988; 3(3):295-9. PubMed ID: 3140104
[TBL] [Abstract][Full Text] [Related]
15. Oxalic Acid as a uremic toxin.
Mydlík M; Derzsiová K
J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441
[TBL] [Abstract][Full Text] [Related]
16. Plasma oxalate levels rise in hemodialysis patients despite increased oxalate removal.
Costello JF; Sadovnic MJ; Cottington EM
J Am Soc Nephrol; 1991 Jun; 1(12):1289-98. PubMed ID: 1912391
[TBL] [Abstract][Full Text] [Related]
17. Effect of pyridoxine supplementation on plasma oxalate concentrations in patients receiving dialysis.
Tomson CR; Channon SM; Parkinson IS; Sheldon WS; Ward MK; Laker MK
Eur J Clin Invest; 1989 Apr; 19(2):201-5. PubMed ID: 2499479
[TBL] [Abstract][Full Text] [Related]
18. [Oxalic acid--important uremic toxin].
Mydlík M; Derzsiová K
Vnitr Lek; 2010 Jul; 56(7):695-701. PubMed ID: 20842915
[TBL] [Abstract][Full Text] [Related]
19. The effect of vitamin C intake on plasma oxalate in patients on regular haemodialysis.
Rolton HA; McConnell KM; Modi KS; Macdougall AI
Nephrol Dial Transplant; 1991; 6(6):440-3. PubMed ID: 1876286
[TBL] [Abstract][Full Text] [Related]
20. Effect of vitamin B6 supplementation on plasma oxalate and oxalate removal rate in hemodialysis patients.
Costello JF; Sadovnic MC; Smith M; Stolarski C
J Am Soc Nephrol; 1992 Oct; 3(4):1018-24. PubMed ID: 1450364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
